FDA Clearance Tracker · P080025-S163
InterStim Therapy System, Verify Evaluation System
Last checked: Nov 20, 2026Latest source record: Jul 3, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 3, 2018
Approved
Time to decision
90 days
Received Apr 4, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080025-S163
- Device name
- InterStim Therapy System, Verify Evaluation System
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Apr 4, 2018
- Decided
- Jul 3, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080025
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval of new models A510 and A520 programmer applications and TH90 kit for INS; update of programming software for models A511 and A521 programmer applications for ENS; labeling revisions.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.